Home / Butylscopolamine / Belgium
BE ATC A03BB01 · updated 2 Nov 2026
Butylscopolamine shortage in Belgium
Is there a Butylscopolamine shortage in Belgium?
Yes. As of 2 Nov 2026, 1 Butylscopolamine product is reported short in Belgium, the first since 16 Oct 2026. The company estimate for the return is 3 Nov 2026. Main reason: manufacturing problem.
Also short in Italy, Norway. All countries.
Affected products in Belgium
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| BE | Buscopan 20 mg/ml inj. sol. i.m./i.v./s.c. amp. 6 x 1 ml | Opella Healthcare Belgium | 16 Oct 2026 | 3 Nov 2026 | Manufacturing problem Delay in the release of the end product |
Source
FAMHP (Federal Agency for Medicines and Health Products), PharmaStatus / SAMv2. Official list. All authorised packs with a declared temporary unavailability.